Baidu
map

IBD:克罗恩病患者的大便频率和腹部疼痛程度与简单内镜评分的相关性分析

2020-01-18 不详 MedSci原创

克罗恩病活动指数(CDAI)因与肠道炎症之间存在的关联比较弱而没有受到重用。因此,本项研究中研究人员评估了克罗恩病的简单内窥镜评分(SES-CD)与按疾病位置分层的单个CDAI项目之间的相关性,以更好地了解这种关系。

背景
克罗恩病活动指数(CDAI)因与肠道炎症之间存在的关联比较弱而没有受到重用。因此,本项研究中研究人员评估了克罗恩病的简单内窥镜评分(SES-CD)与按疾病位置分层的单个CDAI项目之间的相关性,以更好地了解这种关系。

方法
研究人员收集了安慰剂对照的克罗恩病(CD)试验的患者的数据,这些试验测药物包含阿达木单抗,upadacitinib和risankizumab。根据研究开始时的结肠镜检查,将疾病位置定义为回肠,结肠或回结肠。皮尔逊相关系数和线性回归评估了CDAI和SES-CD之间的相关性。

结果
本项研究总共纳入了353名患者(20.7%回肠,30.6%结肠,48.7%回结肠)。克罗恩病活动指数和SES-CD得分呈中等相关性(R = 0.33; P <0.001)。在CDAI项目中,与SES-CD的相关性最强的是粪便频率,及性质;这些相关性在结肠疾病中(SF:R = 0.46; P <0.001; PRO2:R = 0.44; P <0.001)在数值上比回肠疾病(SF:R = 0.14; P = 0.23; PRO2:R = 0.21; P = 0.07)更加明显,在调整后的线性回归模型中,发炎的黏膜比例和溃疡形成的黏膜比例呈正相关。

结论
CDAI中的大便频率项与SES-CD呈中度相关,与黏膜溃疡,炎症和狭窄独立相关。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1798833, encodeId=4d791e9883321, content=<a href='/topic/show?id=08e5e06115f' target=_blank style='color:#2F92EE;'>#疼痛程度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70611, encryptionId=08e5e06115f, topicName=疼痛程度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dc7399, createdName=apoenzyme, createdTime=Wed Oct 21 02:20:00 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941751, encodeId=fd8d1941e5103, content=<a href='/topic/show?id=7b458569204' target=_blank style='color:#2F92EE;'>#腹部疼痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85692, encryptionId=7b458569204, topicName=腹部疼痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02f5179, createdName=luoxiaog, createdTime=Mon Jun 22 07:20:00 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837781, encodeId=1ccb183e7814c, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed May 13 11:20:00 CST 2020, time=2020-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262155, encodeId=5c561262155d2, content=<a href='/topic/show?id=0ceb30545e0' target=_blank style='color:#2F92EE;'>#内镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30545, encryptionId=0ceb30545e0, topicName=内镜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Mon Jan 20 00:20:00 CST 2020, time=2020-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263541, encodeId=1789126354173, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Mon Jan 20 00:20:00 CST 2020, time=2020-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523637, encodeId=3ae8152363ed2, content=<a href='/topic/show?id=f6f1e2533e3' target=_blank style='color:#2F92EE;'>#相关性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72533, encryptionId=f6f1e2533e3, topicName=相关性分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad8f11536374, createdName=anminleiryan, createdTime=Mon Jan 20 00:20:00 CST 2020, time=2020-01-20, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1798833, encodeId=4d791e9883321, content=<a href='/topic/show?id=08e5e06115f' target=_blank style='color:#2F92EE;'>#疼痛程度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70611, encryptionId=08e5e06115f, topicName=疼痛程度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dc7399, createdName=apoenzyme, createdTime=Wed Oct 21 02:20:00 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941751, encodeId=fd8d1941e5103, content=<a href='/topic/show?id=7b458569204' target=_blank style='color:#2F92EE;'>#腹部疼痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85692, encryptionId=7b458569204, topicName=腹部疼痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02f5179, createdName=luoxiaog, createdTime=Mon Jun 22 07:20:00 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837781, encodeId=1ccb183e7814c, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed May 13 11:20:00 CST 2020, time=2020-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262155, encodeId=5c561262155d2, content=<a href='/topic/show?id=0ceb30545e0' target=_blank style='color:#2F92EE;'>#内镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30545, encryptionId=0ceb30545e0, topicName=内镜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Mon Jan 20 00:20:00 CST 2020, time=2020-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263541, encodeId=1789126354173, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Mon Jan 20 00:20:00 CST 2020, time=2020-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523637, encodeId=3ae8152363ed2, content=<a href='/topic/show?id=f6f1e2533e3' target=_blank style='color:#2F92EE;'>#相关性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72533, encryptionId=f6f1e2533e3, topicName=相关性分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad8f11536374, createdName=anminleiryan, createdTime=Mon Jan 20 00:20:00 CST 2020, time=2020-01-20, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1798833, encodeId=4d791e9883321, content=<a href='/topic/show?id=08e5e06115f' target=_blank style='color:#2F92EE;'>#疼痛程度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70611, encryptionId=08e5e06115f, topicName=疼痛程度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dc7399, createdName=apoenzyme, createdTime=Wed Oct 21 02:20:00 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941751, encodeId=fd8d1941e5103, content=<a href='/topic/show?id=7b458569204' target=_blank style='color:#2F92EE;'>#腹部疼痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85692, encryptionId=7b458569204, topicName=腹部疼痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02f5179, createdName=luoxiaog, createdTime=Mon Jun 22 07:20:00 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837781, encodeId=1ccb183e7814c, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed May 13 11:20:00 CST 2020, time=2020-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262155, encodeId=5c561262155d2, content=<a href='/topic/show?id=0ceb30545e0' target=_blank style='color:#2F92EE;'>#内镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30545, encryptionId=0ceb30545e0, topicName=内镜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Mon Jan 20 00:20:00 CST 2020, time=2020-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263541, encodeId=1789126354173, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Mon Jan 20 00:20:00 CST 2020, time=2020-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523637, encodeId=3ae8152363ed2, content=<a href='/topic/show?id=f6f1e2533e3' target=_blank style='color:#2F92EE;'>#相关性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72533, encryptionId=f6f1e2533e3, topicName=相关性分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad8f11536374, createdName=anminleiryan, createdTime=Mon Jan 20 00:20:00 CST 2020, time=2020-01-20, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1798833, encodeId=4d791e9883321, content=<a href='/topic/show?id=08e5e06115f' target=_blank style='color:#2F92EE;'>#疼痛程度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70611, encryptionId=08e5e06115f, topicName=疼痛程度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dc7399, createdName=apoenzyme, createdTime=Wed Oct 21 02:20:00 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941751, encodeId=fd8d1941e5103, content=<a href='/topic/show?id=7b458569204' target=_blank style='color:#2F92EE;'>#腹部疼痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85692, encryptionId=7b458569204, topicName=腹部疼痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02f5179, createdName=luoxiaog, createdTime=Mon Jun 22 07:20:00 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837781, encodeId=1ccb183e7814c, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed May 13 11:20:00 CST 2020, time=2020-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262155, encodeId=5c561262155d2, content=<a href='/topic/show?id=0ceb30545e0' target=_blank style='color:#2F92EE;'>#内镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30545, encryptionId=0ceb30545e0, topicName=内镜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Mon Jan 20 00:20:00 CST 2020, time=2020-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263541, encodeId=1789126354173, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Mon Jan 20 00:20:00 CST 2020, time=2020-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523637, encodeId=3ae8152363ed2, content=<a href='/topic/show?id=f6f1e2533e3' target=_blank style='color:#2F92EE;'>#相关性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72533, encryptionId=f6f1e2533e3, topicName=相关性分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad8f11536374, createdName=anminleiryan, createdTime=Mon Jan 20 00:20:00 CST 2020, time=2020-01-20, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1798833, encodeId=4d791e9883321, content=<a href='/topic/show?id=08e5e06115f' target=_blank style='color:#2F92EE;'>#疼痛程度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70611, encryptionId=08e5e06115f, topicName=疼痛程度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dc7399, createdName=apoenzyme, createdTime=Wed Oct 21 02:20:00 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941751, encodeId=fd8d1941e5103, content=<a href='/topic/show?id=7b458569204' target=_blank style='color:#2F92EE;'>#腹部疼痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85692, encryptionId=7b458569204, topicName=腹部疼痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02f5179, createdName=luoxiaog, createdTime=Mon Jun 22 07:20:00 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837781, encodeId=1ccb183e7814c, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed May 13 11:20:00 CST 2020, time=2020-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262155, encodeId=5c561262155d2, content=<a href='/topic/show?id=0ceb30545e0' target=_blank style='color:#2F92EE;'>#内镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30545, encryptionId=0ceb30545e0, topicName=内镜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Mon Jan 20 00:20:00 CST 2020, time=2020-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263541, encodeId=1789126354173, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Mon Jan 20 00:20:00 CST 2020, time=2020-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523637, encodeId=3ae8152363ed2, content=<a href='/topic/show?id=f6f1e2533e3' target=_blank style='color:#2F92EE;'>#相关性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72533, encryptionId=f6f1e2533e3, topicName=相关性分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad8f11536374, createdName=anminleiryan, createdTime=Mon Jan 20 00:20:00 CST 2020, time=2020-01-20, status=1, ipAttribution=)]
    2020-01-20 bnurmamat
  6. [GetPortalCommentsPageByObjectIdResponse(id=1798833, encodeId=4d791e9883321, content=<a href='/topic/show?id=08e5e06115f' target=_blank style='color:#2F92EE;'>#疼痛程度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70611, encryptionId=08e5e06115f, topicName=疼痛程度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dc7399, createdName=apoenzyme, createdTime=Wed Oct 21 02:20:00 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941751, encodeId=fd8d1941e5103, content=<a href='/topic/show?id=7b458569204' target=_blank style='color:#2F92EE;'>#腹部疼痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85692, encryptionId=7b458569204, topicName=腹部疼痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02f5179, createdName=luoxiaog, createdTime=Mon Jun 22 07:20:00 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837781, encodeId=1ccb183e7814c, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed May 13 11:20:00 CST 2020, time=2020-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262155, encodeId=5c561262155d2, content=<a href='/topic/show?id=0ceb30545e0' target=_blank style='color:#2F92EE;'>#内镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30545, encryptionId=0ceb30545e0, topicName=内镜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Mon Jan 20 00:20:00 CST 2020, time=2020-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263541, encodeId=1789126354173, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Mon Jan 20 00:20:00 CST 2020, time=2020-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523637, encodeId=3ae8152363ed2, content=<a href='/topic/show?id=f6f1e2533e3' target=_blank style='color:#2F92EE;'>#相关性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72533, encryptionId=f6f1e2533e3, topicName=相关性分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad8f11536374, createdName=anminleiryan, createdTime=Mon Jan 20 00:20:00 CST 2020, time=2020-01-20, status=1, ipAttribution=)]

相关资讯

J Gastroenterology:经腹超声检查评估溃疡性结肠炎的有效性分析

据报道,经腹超声检查(US)是评估溃疡性结肠炎(UC)的有效工具,因此,本项前瞻性多中心研究旨在确定与超声检查用于评估UC的疾病程度和活动的有效性。

Digest Liver Dis: 不同直径的冷与热圈套在息肉切除术的切除率和安全性的差异

热圈套(HS)广泛用于切除> 5 mm的腺瘤。冷圈套(CS)则具有更好的安全性,更具成本效益。本研究的目的是评估CS息肉切除术(CSP)与HS息肉切除术(HSP)相比在切除5-10 mm和11-20 mm腺瘤中的有效性和安全性。

Gastroenterology Report: 急性憩室出血患者行早期结肠镜检查可以使医疗资源利用率提高

憩室出血(DB)是发达国家严重急性下消化道出血(GIB)的最常见原因。早期结肠镜检查(< 24小时)的作用仍然存在争议,因此,本项研究的目的是评估结肠镜检查时间对急性DB患者预后的影响。

GUT: 粪便免疫化学测试(FIT)在筛查结直肠癌和息肉切除术后中复发的监测作用

英国肠癌筛查计划(BCSP)建议对患有结直肠癌(CRC)行息肉切除术(有三到四个小腺瘤或一个≥10mm)的中度风险患者进行1年3次结肠镜检查。而本项研究旨在探究粪便免疫化学测试(FITs)是否可以减少内窥镜检查的次数而起到相似的效果。

GUT:连续两次结肠镜检查结果阴性可预测炎症性肠病患者远期结肠癌发生率较低

结肠镜检查被认为可以预防长期结肠性IBD患者发生结直肠癌(CRC)的有效手段,但尚无研究证据表明。因此,本项研究的目的是确定连续阴性结肠镜检查结果是否足以预测较低的肿瘤风险。

BMC Gastroenterology:磁共振肠造影、结肠镜检查和粪钙卫蛋白与结肠克罗恩病的关系

粪便钙卫蛋白(FCP),磁共振肠造影(MRE)和结肠镜检查是用于评估克罗恩病(CD)患者的有效检查手段。虽然先前的研究已经评估了这些测试的组合之间的关联,但尚无研究确定三者之间的相关性。因此,本项研究旨在评估这三个测试之间是否存在相关性,这是否会导致临床结果的改善,是否可用于简化患者监测和治疗选择。

Baidu
map
Baidu
map
Baidu
map